Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cengild Medical BhdXKLS:0243 62 3-1 Month Momentum % is -9.52% as of Aug. 13, 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 62/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 673 Healthcare Providers & Services companies, Cengild Medical Bhd ranks worse than 69.24% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-13), Cengild Medical Bhd's 3-1 Month Momentum % is -9.52%.
The industry rank for Cengild Medical Bhd's 3-1 Month Momentum % or its related term are showing as below:
XKLS:0243's 3-1 Month Momentum % is ranked worse than 69.24% of 673
companies
in the Healthcare Providers & Services industry
Industry Median: -1.73
vs XKLS:0243: -9.52
Cengild Medical Bhd (XKLS:0243) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Cengild Medical Bhd 3-1 Month Momentum % Related Terms
XKLS:0243 vs HCA, THC, DVA: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Cengild Medical Bhd's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cengild Medical Bhd 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Cengild Medical Bhd's 3-1 Month Momentum % falls into.
Cengild Medical Bhd (XKLS:0243) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cengild Medical Bhd (XKLS:0243) has a 3-1 Month Momentum % of -9.52% as of Aug. 13, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cengild Medical Bhd and its competitors. According to the industry distribution chart, Cengild Medical Bhd ranks #466 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 69.2%.
Is Cengild Medical Bhd's 3-1 Month Momentum % too high?
Cengild Medical Bhd's current 3-1 Month Momentum % is -9.52%. Based on the distribution chart, Cengild Medical Bhd ranks #466 out of 673 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cengild Medical Bhd has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cengild Medical Bhd ranks #466 out of 673 companies for 3-1 Month Momentum %. This places Cengild Medical Bhd in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current 3-1 Month Momentum % is -9.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.20 — trading 32.8% below its estimated fair value. The current 3-1 Month Momentum % is -9.52%. Cengild Medical Bhd's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current 3-1 Month Momentum % is -9.52% as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?
Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued.
The current stock price of RM0.20 is trading 32.8% below its estimated GF Value™ of RM0.29.
GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0243:
3-1 Month Momentum %: -9.52%
GF Value™: RM0.29 vs. price of RM0.20 (32.8% below fair value)
No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
62GF Score
Get the complete analysis for XKLS:0243
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0243 has been successfully added to your 
